Compounds > folic acid
Page last updated: 2024-08-17

folic acid and atazanavir sulfate

folic acid has been researched along with atazanavir sulfate in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alnouti, Y; Balkundi, S; Bronich, T; Gautam, N; Gendelman, HE; Gorantla, S; Kabanov, A; Kanmogne, GD; Liu, X; McMillan, J; Poluektova, L; Roy, U; Singh, S; Smith, N; Zhou, Y1
Balkundi, S; Bronich, T; Edagwa, BJ; Gendelman, HE; Kabanov, AV; Kendrick, L; Li, T; Liu, XM; McMillan, J; Puligujja, P; Smith, N; Veerubhotla, RS1
Alnouti, Y; Balkundi, S; Fox, HS; Gautam, N; Gendelman, HE; Liu, XM; McMillan, J; Puligujja, P; Thakare, R1
Araínga, M; Dash, P; Gendelman, HE; Gorantla, S; McMillan, J; Mosley, RL; Palandri, D; Poluektova, L; Puligujja, P1
Boska, MD; Bronich, TK; Edagwa, B; Gendelman, HE; Li, T; Liu, XM; McMillan, JM; Puligujja, P; Zhang, G1

Other Studies

5 other study(ies) available for folic acid and atazanavir sulfate

ArticleYear
Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
    International journal of nanomedicine, 2012, Volume: 7

    Topics: Adult; Animals; Anti-Retroviral Agents; Atazanavir Sulfate; Blood-Brain Barrier; Brain; Cells, Cultured; Coculture Techniques; Drug Carriers; Drug Delivery Systems; Endothelial Cells; Folic Acid; HIV Infections; Humans; Male; Mice; Mice, Inbred NOD; Mice, SCID; Microscopy, Fluorescence; Mononuclear Phagocyte System; Nanoparticles; Oligopeptides; Pyridines; Ritonavir; Spleen; Tissue Distribution; Viral Load

2012
Macrophage folate receptor-targeted antiretroviral therapy facilitates drug entry, retention, antiretroviral activities and biodistribution for reduction of human immunodeficiency virus infections.
    Nanomedicine : nanotechnology, biology, and medicine, 2013, Volume: 9, Issue:8

    Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Cells, Cultured; Drug Delivery Systems; Folate Receptors, GPI-Anchored; Folic Acid; HIV Infections; HIV-1; Humans; Macrophages; Male; Mice; Mice, Inbred BALB C; Oligopeptides; Pyridines; Tissue Distribution

2013
Pharmacokinetics, biodistribution, and toxicity of folic acid-coated antiretroviral nanoformulations.
    Antimicrobial agents and chemotherapy, 2014, Volume: 58, Issue:12

    Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Drug Administration Schedule; Drug Carriers; Drug Compounding; Drug Evaluation, Preclinical; Folic Acid; Food, Formulated; Half-Life; Humans; Injections, Intramuscular; Macaca mulatta; Male; Mice; Mice, Inbred C57BL; Nanostructures; Oligopeptides; Poloxamer; Pyridines; Ritonavir; Tissue Distribution

2014
Pharmacodynamics of folic acid receptor targeted antiretroviral nanotherapy in HIV-1-infected humanized mice.
    Antiviral research, 2015, Volume: 120

    Topics: Animals; Anti-Retroviral Agents; Atazanavir Sulfate; CD4 Lymphocyte Count; Delayed-Action Preparations; Drug Carriers; Folate Receptors, GPI-Anchored; Folic Acid; HIV Infections; Humans; Injections, Intramuscular; Mice, SCID; Nanomedicine; Nanoparticles; Poloxamer; Ritonavir; RNA, Viral; Treatment Outcome; Viral Load

2015
Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.
    International journal of nanomedicine, 2015, Volume: 10

    Topics: Alendronate; Animals; Anti-Retroviral Agents; Atazanavir Sulfate; Dextrans; Drug Delivery Systems; Folic Acid; Macrophages; Magnetic Resonance Imaging; Magnetite Nanoparticles; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Mononuclear Phagocyte System; Nanomedicine; Reproducibility of Results; Tissue Distribution

2015